Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04104594Terminated
Open-label trial in chronic rhinosinusitis with nasal polyps (CRSwNP) and Olfactory disorder (2 arms), sponsored by CHU Saint-Etienne. Primary endpoints: expression rate of TNF-alpha in biopsies at 2 months and Sniffin Stick test score at 2 months. Started Feb 2020; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04104594.